Clinical Trials
4 trialsNCT07492641 2026-06-03
KANDELA-302
BeOne Medicines
Phase 3 Recruiting
NCT06998407 2026-05-04
AVZO-023-1001
Avenzo Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07130643 2025-08-19
Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer
Hubei Cancer Hospital
Phase 2 Active not recruiting
NCT06860529 2025-06-23
Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer
Henan Cancer Hospital
Phase 2 Recruiting